Keyphrases
Phosphodiesterase
100%
Heart Failure Treatment
100%
Phosphodiesterase Inhibitors
100%
Cardiovascular System
66%
Heart Failure
66%
Contractility
33%
Apoptosis
33%
Cyclic GMP
33%
Second Messenger
33%
Cardiac muscle
33%
Metabolic Pathway
33%
Hypertrophy
33%
Intracellular Metabolism
33%
Fibrosis
33%
Cyclic Adenosine Monophosphate (cAMP)
33%
Phosphodiester Bond
33%
As(III)
33%
Cyclic nucleotides
33%
Cyclic nucleotide Phosphodiesterase
33%
Indirect Regulation
33%
Adenosine 3′
33%
Selective Hydrolysis
33%
Cyclic Function
33%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Phosphodiesterase Inhibitor
100%
Phosphodiesterase
75%
Fibrosis
25%
Lead Compound
25%
Cyclic AMP
25%
Cyclic Nucleotide Phosphodiesterase
25%
Cyclic GMP
25%
Cyclic Nucleotide
25%
Phosphodiester Bond
25%